Back to Search
Start Over
Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective.
- Source :
- CTS: Clinical & Translational Science; May2021, Vol. 14 Issue 3, p781-783, 3p
- Publication Year :
- 2021
-
Abstract
- Nonalcoholic fatty liver disease (NAFLD) affects up to 70% of children with obesity and has become the number one etiology for liver transplant in the United States. Early, effective intervention is critical to prevent disease progression into adulthood. Yet, it is seldom achieved through lifestyle modification alone. Thus, children must be included in NAFLD pharmacology trials, which, to date, continue to focus primarily on adult populations. This commentary serves as a call to action. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 17528054
- Volume :
- 14
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- CTS: Clinical & Translational Science
- Publication Type :
- Academic Journal
- Accession number :
- 150966429
- Full Text :
- https://doi.org/10.1111/cts.12952